The Chemicals Your Safety Lead Doesn't Own: SDS Review and Exposure Risks in Cleanroom Materials Development

Your battery materials lab is running electrolyte tests on a new formulation. Your semiconductor pilot line is processing photoresist. Your nanotech bench is handling carbon nanotubes that arrived with sparse hazard data.

One of those chemicals just killed someone.

In 2003, a young semiconductor worker in Taiwan sprayed himself with tetramethylammonium hydroxide (TMAH) — a solution routinely used for photoresist stripping. Twenty-nine percent of his body was exposed. He was wearing a cleanroom suit. Eight days later, he was dead. The cause: both corrosive effects and systemic cholinergic toxicity that shut down his respiratory function.

What made that death preventable was not a mystery chemical. It was organizational clarity: someone needed to own the fact that TMAH has no OSHA permissible exposure limit (PEL) and no NIOSH recommended exposure limit (REL), and that absence is itself the hazard.

Materials development facilities — battery labs, semiconductor pilot lines, medical device R&D — operate in a compliance blind spot. The materials science team orders the chemistry. The safety department tracks OSHA compliance. The purchasing team files the Safety Data Sheets somewhere. Nobody owns the bridge between what’s on the SDS and what’s actually happening on the bench.

That gap is where we start.

The Regulatory Framework Nobody Reads

Two OSHA standards apply to your cleanroom, depending on scale and scope.

OSHA 29 CFR 1910.1450 — the Laboratory Standard — applies if your facility is “engaged in laboratory use of hazardous chemicals” (29 CFR 1910.1450). This standard requires a written Chemical Hygiene Plan (CHP), readily accessible Safety Data Sheets, exposure minimization through engineering controls and PPE, and designation of a Chemical Hygiene Officer.

The critical language: “engaged in laboratory use.” This is a facts-and-circumstances test. A small R&D team evaluating five samples per month of a new electrolyte formula may not trigger the Lab Standard. A production-scale pilot line running the same chemistry 40 hours per week almost certainly does. The ambiguity is intentional — employers must self-assess and document the determination. Many do not.

OSHA 29 CFR 1910.1200 — the Hazard Communication Standard (HazCom) — applies regardless of Lab Standard coverage. HazCom requires manufacturers, importers, and distributors to classify hazards and provide Safety Data Sheets to users. The newly finalized HazCom 2024 rule updates these requirements to align with the UN Globally Harmonized System (GHS) Revision 7 and selected elements of Revision 8 (OSHA HazCom 2024).

The implication is massive: approximately 95% of substance Safety Data Sheets and 64% of all labels will be revised under HazCom 2024 compliance deadlines that run through January 2028. For facilities with extensive chemical inventories — battery labs, semiconductor cleanrooms, nanomaterials operations — SDS review cycles will be continuous.

But the regulatory framework is only the container. The hazard is what goes inside.

TMAH: The Absence of an Exposure Limit Is the Hazard

Tetramethylammonium hydroxide is used extensively in semiconductor fabs and R&D cleanrooms for photoresist stripping. It is not regulated by an OSHA permissible exposure limit. It is not regulated by a NIOSH recommended exposure limit.

This is not because TMAH is low-hazard. This is because TMAH is too acutely hazardous to rely on exposure limits alone.

TMAH is both a corrosive base and a cholinergic agonist. It causes rapid liquefaction necrosis at skin contact sites and systemic cholinergic toxicity that depresses respiratory function. A worker drenched in 2.38% TMAH experienced cardiac arrest within 20 minutes, losing consciousness and developing seizure-like movements (TMAH dermal exposure presentations, PMC).

The 2003 Taiwan fatality is not an outlier. It is a documented reminder of what happens when the organizational responsibility for TMAH safety is ambiguous.

Here is what OSHA expects: If you use TMAH, you have no PEL to hide behind. You cannot say “we keep exposures below the limit.” There is no limit. You must instead engineer the hazard away entirely. Closed dispensing systems. No overhead containers. No spray applications. Full-body impermeable PPE. Immediate decontamination protocols. Emergency calcium gluconate availability (the specific antidote for fluoride toxicity).

Many materials development teams review a TMAH SDS, see the blank space where the PEL would be, and assume the chemical is “not regulated.” This is the exact moment where organizational failure begins.

Source: Tetramethylammonium hydroxide fatality case studies (PubMed), TMAH dermal exposure presentations (PMC).

Hydrofluoric Acid: When the PEL Itself Is Deceiving

Hydrofluoric acid is used in wet etching, cleaning, and specialty polishing processes in semiconductor and materials labs. The OSHA PEL is 3 ppm. This PEL is deceptively permissive.

HF is different from other mineral acids because the fluoride ion (F⁻) readily penetrates intact skin. Once inside tissue, fluoride ion causes:

Liquefaction necrosis
Ion-selective destruction of bone calcium
Continued tissue destruction for days if not treated
Systemic uptake causing life-threatening electrolyte disturbances (hypocalcemia, hyperkalemia)
In untreated cases, limb loss or death

NIOSH classifies HF with a skin notation for systemic fatal effects via direct absorption and corrosive effects. The ACGIH TLV is 0.5 ppm — six times more stringent than the OSHA PEL.

What this means: You cannot rely on the “3 ppm PEL” on an HF SDS as reassurance. That number exists for regulatory compliance purposes, not for actual safe handling. Your engineering controls must prevent any meaningful exposure. No open containers in occupied spaces. Dilution to <50% where possible. Rapid emergency medical protocols, including calcium gluconate availability and treatment competency among facility staff.

Source: NIOSH HF Skin Notation Profile, OSHA HF Hazard Information.

The Nanoparticle Void: NIOSH REL Without OSHA Teeth

Materials development in battery, semiconductor, and advanced materials labs increasingly uses carbon nanotubes and engineered nanoparticles. OSHA has no PEL for these materials.

NIOSH issued CIB 65 (2013) recommending a recommended exposure limit (REL) of 1 microgram per cubic meter (μg/m³) elemental carbon as respirable mass, 8-hour TWA. Animal studies show adverse lung effects — pulmonary inflammation, persistent fibrosis — at relatively low doses. Whether humans experience the same effects is unknown. The burden-of-proof standard is reversed: assume harm and minimize exposure.

Here is the practical problem: Cleanrooms with nanoparticle processes often have no exposure monitoring. Standard air monitoring for particles — optical particle counters — does not differentiate nanoparticles from other particulates. Real-time monitoring for nanoparticles requires specialized equipment (electron microscopy, mass spectrometry) rarely deployed in R&D settings.

Many purchased nanoparticle products — carbon nanotubes, graphene, metal oxides — arrive with SDSs that list “no established PEL” and lack hazard assessment data. The NIOSH CIB 65 REL is not legally enforceable like OSHA PELs, but it represents current best science. The regulatory uncertainty is real. How you handle it signals whether your facility has a compliance culture or just compliance compliance.

Source: NIOSH CIB 65 — Carbon Nanotubes and Nanofibers.

Photoresist Solvents: The Regulatory Escalation Coming in 2026

N-methylpyrrolidone (NMP) and propylene glycol methyl ether acetate (PGMEA) are the primary solvents for photoresist removal in semiconductor fabs and R&D cleanrooms. Both are common. Both have OSHA exposure limits. Both are facing increasing regulatory scrutiny that your SDS review process may have missed.

NMP status: EPA has designated NMP for risk evaluation under the Toxic Substances Control Act (TSCA). This signals potential regulatory restrictions on manufacturing or use. NMP also has developmental and reproductive toxicity concerns documented in animal studies (EPA NMP Risk Evaluation).

PGMEA status: Commonly used; less scrutinized than NMP nationally, but California and several states monitor closely.

For materials development teams, the implication is this: If you operate in California or supply California-bound products, you must monitor Prop 65 listings and EPA TSCA actions. A solvent that is currently permissible may face restrictions within 12–24 months. Your compliance program needs to catch that shift.

Source: EPA NMP Risk Evaluation, NIOSH NMP Method 1302.

Who Owns the SDS? The Organizational Accountability Gap

This is the core problem in materials development facilities: The SDS exists. It is filed. But no single person or team owns the bridge between the SDS and actual facility operations.

The materials scientist sees the SDS as a compliance checkbox. The safety manager sees it as a health hazard document outside their domain. Purchasing sees it as a shipping requirement. Facilities sees it as someone else’s responsibility.

Meanwhile, someone is using TMAH without knowing there is no PEL. Someone is handling nanoparticles with no exposure monitoring. Someone is mixing photoresist solvents with unknown reproductive hazard implications.

OSHA’s enforcement pattern bears this out. The most common violation in lab and cleanroom settings is not a specific chemical exposure — it is a missing or inadequate Chemical Hygiene Plan. The second most common is SDS not readily accessible. The third is failure to establish exposure limits or conduct hazard assessment.

HazCom 2024: The Compliance Timeline You Cannot Afford to Miss

The HazCom 2024 rule introduces new hazard classifications and labeling requirements. The deadline structure is staggered:

January 19, 2026: Manufacturers and importers must update labels and SDSs for substances per HazCom 2024 (GHS 7 + selected GHS 8 elements).
July 19, 2027: Manufacturers and importers must update labels and SDSs for mixtures.
July 20, 2026: Employers (users) must update internal labels and chemical hygiene documentation for substances per new SDSs.
January 19, 2028: Employers must update internal labels and documentation for mixtures.

OSHA estimates that 95% of substance SDSs and 64% of all labels will be revised. For facilities with extensive chemical inventories, this is not a one-time compliance task — it is continuous work through 2028.

Assign ownership. Create a process. Plan for 2–3 months of review and training per update wave. If you do not, you will face either a compliance gap or reactive crisis management when the SDS arrives and nobody knows how it changes your exposure controls.

Five Steps to Cleanroom Chemical Compliance

If your materials development facility handles OSHA-regulated chemicals or falls under OSHA 1910.1450, these are the actionable tasks:

1. Identify applicable scope. Document whether your facility meets the definition of “laboratory” under 1910.1450. If yes, a Chemical Hygiene Plan is required. If borderline, consult industrial hygiene or legal counsel. This determination is not optional — it is an OSHA expectation.

2. Collect and review all Safety Data Sheets. Ensure SDSs are:

Current (review dates; HazCom 2024 will trigger massive updates 2026–2028).
Accessible to all workers (physical and/or digital; OSHA expects reasonably prompt access).
Specifically reviewed for skin notation hazards, especially HF and TMAH.

3. Develop or update your Chemical Hygiene Plan. The CHP must address:

Standard operating procedures for hazardous chemical use.
Engineering controls (ventilation, fume hoods, closed systems for high-risk chemicals).
Administrative controls (worker rotation, duty assignment, training frequency).
Personal protective equipment requirements by chemical and process.
Emergency procedures (eyewash, shower, chemical spill response, first aid).
Medical surveillance if exposures exceed de minimis levels.
Designation of a Chemical Hygiene Officer.

4. Conduct hazard assessments for high-risk chemicals. Specific chemicals warrant professional industrial hygiene consultation:

TMAH operations: Engineering controls (closed dispensing, no spray), emergency protocols (calcium gluconate availability, rapid decontamination).
HF operations: Local exhaust ventilation, rapid emergency response training, medical pre-planning.
Nanoparticle processes: Air monitoring for nanoparticle concentration if CIB 65 REL is relevant.

5. Train workers and document hazard communication. All workers handling or potentially exposed to hazardous chemicals must receive training covering:

SDS interpretation under HazCom 2024.
Hazard-specific controls (why TMAH has no PEL, why HF penetrates skin, why nanoparticles carry uncertainty).
Emergency procedures and first aid.

Where iSi Fits

Materials development teams often have the chemistry dialed in but the safety infrastructure vague. You know your electrolytes. You know your photoresists. What you may not own is the organizational clarity around who is responsible for SDS review, exposure monitoring, and emergency protocols for the high-hazard chemicals on your bench.

iSi’s cleanroom compliance review program — led by senior industrial hygienists with field experience in battery, semiconductor, and advanced materials facilities — provides that clarity. We conduct a comprehensive SDS and Chemical Hygiene Plan review, identify exposure risks specific to your chemistry and pilot processes, recommend engineering and administrative controls, and establish a training and monitoring framework that actually fits your operation.

The goal is simple: Every chemical in your cleanroom has a clear owner, clear exposure controls, and clear emergency protocols. No organizational gaps. No assumptions. No surprises.

This is the work that prevents incidents. It is also the work that, when an OSHA inspector arrives or a regulatory agency asks, proves you knew what was on your bench and you managed it.